Home › Endometrial Cancer › Georgia › Atlanta
Endometrial Cancer clinical trials in Atlanta, GA
17 studies for Endometrial Cancer are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- and 1 more
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Winship Cancer Institute of Emory University, Atlanta
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- Emory Winship Cancer Institute, Atlanta
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- Piedmont Healthcare, Atlanta
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RecruitingPhase 2
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Piedmont Hospital, Atlanta
- and 3 more
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecruitingPhase 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RecruitingPhase 3
- Emory Winship Cancer Inst., Atlanta
- Emory Winship Cancer Inst., Atlanta
- Northside Hospital Atlanta, Atlanta
- and 1 more
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- Emory University, Atlanta
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
- Winship Cancer Institute, Emory University, Atlanta
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RecruitingPhase 2
- Emory University, Atlanta
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- Winship Cancer Institute of Emory University, Atlanta
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Winship Cancer Institute, Emory University, Atlanta
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RecruitingPhase 1/2
- Winship Cancer Institute, Emory University, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Atlanta
A Beta-only IL-2 ImmunoTherapY Study
RecruitingPhase 1/2
- Emory - Winship Cancer Institute, Atlanta
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RecruitingPhase 2/3
- Northside Hospital, Atlanta
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
- Oklahoma City, OK25 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Multiple Myeloma42 studies
- Breast Cancer41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia31 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Metastatic Cancer28 studies
- Major Depressive Disorder25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.